Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 3
2007 1
2008 1
2009 6
2010 6
2011 6
2012 3
2013 7
2014 10
2015 5
2016 5
2017 8
2018 6
2019 4
2020 2
2021 5
2022 7
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.
Thomas PS, Patel AB, Lee JJ, Liu DD, Hernandez M, Muzzio M, Contreras A, Sepeda V, Mays C, Weber D, Vornik LA, Khan SA, Dimond E, Heckman-Stoddard BM, Perloff M, Brown PH. Thomas PS, et al. Among authors: contreras a. Cancer Prev Res (Phila). 2023 Jan 4;16(1):47-55. doi: 10.1158/1940-6207.CAPR-22-0210. Cancer Prev Res (Phila). 2023. PMID: 36228112 Free PMC article. Clinical Trial.
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.
Mazumdar A, Tahaney WM, Hill JL, Zhang Y, Ramachandran S, Kawedia J, Qian J, Contreras A, Savage MI, Vornik LA, Sei S, Mohammed A, Brown PH. Mazumdar A, et al. Among authors: contreras a. Cancer Prev Res (Phila). 2022 Dec 1;15(12):791-802. doi: 10.1158/1940-6207.CAPR-22-0106. Cancer Prev Res (Phila). 2022. PMID: 35981902 Free PMC article.
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation.
Kumar T, Hobbs E, Yang F, Chang JT, Contreras A, Cuentas ERP, Garber H, Lee S, Lu Y, Scoggins ME, Adrada BE, Whitman GJ, Arun BK, Mittendorf EA, Litton JK. Kumar T, et al. Among authors: contreras a. Clin Cancer Res. 2022 Sep 1;28(17):3669-3676. doi: 10.1158/1078-0432.CCR-21-1278. Clin Cancer Res. 2022. PMID: 35736816 Free PMC article.
86 results